Nurami Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
28
- Latest Deal Type
-
2ndary - Open
- Investors
-
10
Nurami General Information
Description
Manufacturer of bioresorbable surgical implants designed for soft tissue repair. The company offers multilayer dural repair grafts, soft tissue implants, surgical sealants, cranial surgical grafts, spinal surgical grafts, and bioresorbable scaffolds, enabling neurosurgeons to prevent cerebrospinal fluid leakage and promote natural tissue regeneration through electrospun nanofiber technology.
Contact Information
Website
www.nurami-medical.comCorporate Office
- 36 Ha-Namal Street
- Haifa 3303203
- Israel
Corporate Office
- 36 Ha-Namal Street
- Haifa 3303203
- Israel
Nurami Timeline
Nurami Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Secondary Transaction - Open Market | 01-Apr-2026 | Completed | Generating Revenue | |||
| 16. Later Stage VC | 29-Jun-2025 | Completed | Generating Revenue | |||
| 15. Grant | 16-Jul-2024 | Completed | Generating Revenue | |||
| 14. Later Stage VC | 16-Jul-2024 | Completed | Generating Revenue | |||
| 13. Accelerator/Incubator | 03-Jun-2024 | Completed | Generating Revenue | |||
| 12. Grant | 01-Jan-2023 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 01-Aug-2022 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 9. Grant | 01-Jan-2021 | $790K | $9.3M | Completed | Generating Revenue | |
| 8. Accelerator/Incubator | $9.3M | Completed | Generating Revenue |
Nurami Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred B-1 | ||||||||
| Preferred B-2 | ||||||||
| Preferred A | 136,088 | $0.010000 | $44.09 | $44.09 | 1x | $44.09 | 17.13% | |
| Ordinary A | 4,000,000 | $0.010000 | $14.63 | $14.63 | 1x | $14.63 | 10.98% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nurami Comparisons
Industry
Financing
Details
Nurami Competitors (3)
One of Nurami’s 3 competitors is Regenity Biosciences, a Private Equity-Backed company based in Paramus, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Regenity Biosciences | Private Equity-Backed | Paramus, NJ | ||||
| Stryker | Formerly VC-backed | Portage, MI | ||||
| Integra LifeSciences Holdings | Corporation | Princeton, NJ |
Nurami Patents
Nurami Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026190784-A1 | A tissue-adhesive matrix and uses thereof | Pending | 11-Mar-2025 | ||
| AU-2024349836-A1 | A multi-layered matrix and uses thereof | Pending | 28-Sep-2023 | ||
| EP-4784180-A1 | A multi-layered matrix and uses thereof | Pending | 28-Sep-2023 | ||
| WO-2025069037-A1 | A multi-layered matrix and uses thereof | Inactive | 28-Sep-2023 | ||
| US-20260200203-A1 | Multi-layered matrix and uses thereof | Pending | 28-Sep-2023 | B32B5/02 |
Nurami Signals
Nurami Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Accelerator/Incubator | Minority | ||
| MedTech Innovator | Accelerator/Incubator | |||
| Arieli Group | Venture Capital | Minority | ||
| Almeda Ventures | Venture Capital | Minority | ||
| GlenRock Israel | Growth/Expansion | Minority |
Nurami FAQs
-
When was Nurami founded?
Nurami was founded in 2014.
-
Where is Nurami headquartered?
Nurami is headquartered in Haifa, Israel.
-
What is the size of Nurami?
Nurami has 28 total employees.
-
What industry is Nurami in?
Nurami’s primary industry is Surgical Devices.
-
Is Nurami a private or public company?
Nurami is a Private company.
-
What is Nurami’s current revenue?
The current revenue for Nurami is .
-
How much funding has Nurami raised over time?
Nurami has raised $43.7M.
-
Who are Nurami’s investors?
European Innovation Council, MedTech Innovator, Arieli Group, Almeda Ventures, and GlenRock Israel are 5 of 10 investors who have invested in Nurami.
-
Who are Nurami’s competitors?
Regenity Biosciences, Stryker, and Integra LifeSciences Holdings are competitors of Nurami.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process